Daniel Bock

Daniel Bock has extensive experience in business and corporate development in the pharmaceutical and biotechnology industries. Daniel is currently the Senior Director of Business and Corporate Development at Theratechnologies Inc. Prior to this role, they served as the Vice President of Business Development at Dalriada Drug Discovery Inc. and NEOMED Institute. Earlier in their career, they held various senior-level positions at GlaxoSmithKline Inc., Ambrilia Biopharma Inc., BioSignal Packard Inc., and Millipore Corporation. Daniel's expertise lies in strategic planning, partnerships, and licensing.

Daniel Bock completed their education history as follows:

- From 1982 to 1984, they attended the University of the Witwatersrand where they earned a Bachelor of Science degree in Zoology & Microbiology.

- In 1985, they pursued further studies at the same institution and obtained a Bachelor of Science degree with Honours in Microbiology.

- Lastly, from 1987 to 1991, they completed their educational journey at the University of Wollongong, where they earned a Ph.D. in Microbiology.